Oncology & Cancer

Three DNA methylation markers ID recurrence in bladder cancer

(HealthDay)—For patients with noninvasive urothelial carcinoma, three DNA methylation markers are able to accurately predict tumor recurrence, according to a study published in the April 1 issue of Clinical Cancer Research.

Oncology & Cancer

Cetuximab, paclitaxel combo active in urothelial cancer

(HealthDay)—The monoclonal antibody against epidermal growth factor receptor (EGFR), cetuximab, augments the antitumor activity of paclitaxel in patients with previously treated urothelial cancer, according to a study published ...

page 3 from 3